Propionibacterineae

LexaGene’s MiQLab Detects Common Bioreactor Contaminant up to 300 Times Faster than Conventional Methods

Retrieved on: 
Tuesday, July 20, 2021
Propionibacterineae, Sexually transmitted diseases and infections, Infectious causes of cancer, Taxa, Bacterial vaginosis, Infertility, Mycoplasma, Cutibacterium, Medical specialties

Last month, LexaGene announced it could detect Cutibacterium acnes 36 to 168 times faster than conventional methods.

Key Points: 
  • Last month, LexaGene announced it could detect Cutibacterium acnes 36 to 168 times faster than conventional methods.
  • We expect the time benefit of MiQLab Mycoplasma Test to be up to 300 times faster than conventional methods.
  • LexaGenes results demonstrate that the MiQLab system can serve as a valid alternative to lengthy traditional methods for mycoplasma detection.
  • Given the MiQLab can be up to 300 times faster than traditional culture testing (~2 hours versus ~28 days) for a definitive result, the MiQLab can provide a significant time advantage for biopharmaceutical manufacturers.